SAN DIEGO, Oct. 31, 2023 /PRNewswire/ — On 3 November, 2023, the “Designing Chips with CHIPS: West Coast Pre-Silicon Summit” will gather influential minds in the chip design and packaging industry, along with key government policy makers, for a one-day, in-person summit at Irwin M Jacobs Qualcomm Hall in Qualcomm Headquarters, San Diego, California. This… Continue reading Designing Chips with CHIPS: West Coast Pre-Silicon Summit to Convene Industry Leaders in San Diego
Category: Newswire
SANMINA CORPORATION INVITES YOU TO JOIN ITS FOURTH QUARTER AND FISCAL YEAR 2023 EARNINGS CONFERENCE CALL
SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ — Sanmina Corporation (NASDAQ: SANM) announced today that it will host its fourth quarter and fiscal year 2023 earnings conference call on Monday, November 6, 2023 at 4:30 PM ET. The live webcast presentation and supporting materials will be available on the Sanmina Investor Relations website located at… Continue reading SANMINA CORPORATION INVITES YOU TO JOIN ITS FOURTH QUARTER AND FISCAL YEAR 2023 EARNINGS CONFERENCE CALL
Hefty Seed Company choisit la technologie brevetée BIO-CAPSULETM de Meristem
« … un partenariat extrêmement intéressant pour notre clientèle… » BALTIC, Dakota du Sud et COLUMBUS, Ohio, 31 octobre 2023 /PRNewswire/ — Meristem Crop Performance Group, LLC (www.MeristemAg.com) et Hefty Seed Company (www.HeftySeed.com) ont annoncé aujourd’hui la conclusion d’une alliance stratégique et d’une entente d’approvisionnement visant à augmenter les retombées des produits biologiques bénéfiques sur la production… Continue reading Hefty Seed Company choisit la technologie brevetée BIO-CAPSULETM de Meristem
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
DUBLIN, Oct. 31, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the Registration Statement on Form 10, as amended (Form 10), filed by Mural Oncology plc (Mural Oncology) was declared effective by the U.S. Securities and Exchange Commission (SEC). This Form 10 describes Alkermes’ planned separation of its oncology business into Mural Oncology,… Continue reading Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
Breast cancer doesn’t end with October: Methodist Le Bonheur Healthcare takes the guesswork out of deciding when to get a mammogram
MEMPHIS, Tenn., Oct. 31, 2023 /PRNewswire/ — Methodist Le Bonheur Healthcare speaks with a surgical oncologist about the best age to begin routine breast cancer mammogram screenings. Ryland Gore, M.D., breast surgical oncologist with the Methodist Cancer Institute says, “At what age to start screening usually depends on a woman’s personal risk factors and family… Continue reading Breast cancer doesn’t end with October: Methodist Le Bonheur Healthcare takes the guesswork out of deciding when to get a mammogram
BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
VANCOUVER, BC, TORONTO and LONDON, Oct. 31, 2023 /PRNewswire/ – BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC: BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the “Company”) completed its first shipment of Canadian certified organic, EU GMP medical cannabis to the UK on October 25, 2023. The Company is… Continue reading BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
EnLink Midstream Reports Third Quarter 2023 Results
DALLAS, Oct. 31, 2023 /PRNewswire/ — EnLink Midstream, LLC (NYSE: ENLC) (EnLink) reported financial results for the third quarter of 2023. Highlights Reported net income of $65.8 million and net cash provided by operating activities of $274.2 million for the third quarter of 2023. Generated adjusted EBITDA, net to EnLink, of $341.9 million for the third… Continue reading EnLink Midstream Reports Third Quarter 2023 Results
Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
The overall market of primary sclerosing cholangitis (PSC) is expected to boost due to the expected launch of emerging therapy in the forecasted period (2023–2032). LAS VEGAS, Oct. 31, 2023 /PRNewswire/ — DelveInsight’s Primary Sclerosing Cholangitis Market Insights report includes a comprehensive understanding of current treatment practices, primary sclerosing cholangitis emerging drugs, market share of individual… Continue reading Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
Payfare to Hold Investor Conference Call to Discuss Third Quarter 2023 Financial Results
TORONTO, Oct. 31, 2023 /PRNewswire/ – Payfare Inc. (“Payfare” or the “Company”) (TSX: PAY) (OTCQX: PYFRF) will be hosting a conference call on Wednesday, November 8, 2023, at 6:30 p.m. ET to discuss the Company’s financial results for the third quarter of 2023. The complete financial results are expected to be released shortly after market close on… Continue reading Payfare to Hold Investor Conference Call to Discuss Third Quarter 2023 Financial Results
Taseko Mines Announces that the UIC Permit for Florence Copper is now Effective
VANCOUVER, BC, Oct. 31, 2023 /PRNewswire/ – Taseko Mines Limited (TSX: TKO) (NYSE American: TGB) (LSE: TKO) (“Taseko” or the “Company”) is pleased to announce that the US Environmental Protection Agency (“EPA”) has confirmed that no appeals have been received and Florence Copper’s final Underground Injection Control (“UIC”) permit is now effective. Stuart McDonald, President and… Continue reading Taseko Mines Announces that the UIC Permit for Florence Copper is now Effective